Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 68.52 M82.33 M81.02 M86.24 M 318.12 M Research & development ———— — Operating income 51.26 M50.33 M44.65 M48.16 M 194.4 M Non-Operating Income, Total -2.93 M-2.15 M-1.91 M-5.37 M -12.36 M Interest expense, net of interest capitalized 12.61 M12.55 M10.73 M10.99 M 46.89 M Non-Operating Income, excl. Interest Expenses -15.55 M-14.69 M-12.64 M-16.36 M -59.24 M Unusual income/expense ———— — Pretax income 36.27 M36.42 M32.31 M32.34 M 137.35 M Equity in earnings ———— — Taxes 9.74 M8.97 M8.29 M10.63 M 37.63 M Non-controlling/minority interest ———— — After tax other income/expense 474 K351 K534 K554 K 1.91 M Net income before discontinued operations 26.53 M27.46 M24.02 M21.71 M 99.72 M Discontinued operations ———— — Net income 26.53 M27.46 M24.02 M21.71 M 99.72 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 26.53 M27.46 M24.02 M21.71 M 99.72 M Basic earnings per share (Basic EPS) 0.650.680.590.54 2.46 Diluted earnings per share (Diluted EPS) 0.650.670.590.52 2.43 Average basic shares outstanding 40.53 M40.53 M40.55 M40.55 M — Diluted shares outstanding 40.88 M40.96 M41.04 M40.96 M — EBITDA 66.17 M57.87 M55.25 M53.68 M 232.96 M EBIT 53.34 M44.98 M42.8 M40.33 M 181.45 M Cost of revenue 244.11 M241.25 M257.87 M262.35 M 1.01 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 12.83 M12.89 M12.45 M13.35 M 51.51 M